Why Arbutus Biopharma Is Rocketing Higher Today
Shares of Arbutus Biopharma (NASDAQ: ABUS) rocketed higher on Wednesday morning in response to a court ruling in its favor. The stock was up 70.2% at 11:41 a.m. on Wednesday.
Moderna's (NASDAQ: MRNA) attempt to avoid paying royalties on the lipid nanoparticle (LNP) technology that its COVID vaccine relies upon took another turn for the worse. A court of appeals decision filed today affirms the U.S. Patent and Trademark Office's previous decision not to invalidate Arbutus Biopharma's patents covering LNPs.
Image source: Getty Images.
Source Fool.com
